Researchers Submit Patent Application, 'Use Of Snat2 Competitive Inhibitor Or Gene Expression Inhibition In The Preparation Of Drugs For The Prevention And/Or Treatment Of Hypertension', for Approval (USPTO 20240374548)

2024 DEC 6 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Patent Business Week -- From Washington, D.C., NewsRx journalists report that a patent application by the inventors [...]